secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2023-06-22T23:59:59+00:00
Accession:  0001628280-23-023124
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics announces 2023 annual meeting results; all director nominees elected and auditor ratified
--------------------------------------------------------------------------------

- Douglas Cole elected with 19,470,509 for, 2,142,125 against; Gill elected with 21,481,572 for, 144,160 against.
- Parshall elected with 21,600,133 for, 25,599 against; there were 9,648,103 broker non-votes on director election.
- Ratification of Deloitte & Touche as auditor passed with 31,282,179 for, 858 against, 9,849 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828023023124/0001628280-23-023124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828023023124/fhtx-20230621.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-023124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer